NASDAQ
Caribou Biosciences, Inc. (CRBU) has a free cash flow growth of -31.29% as of Friday, May 29, 2026. This represents a 353.11% decrease compared to its 12-month average of 12.36%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.